• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WANG Zhuo,LIU Huaiying.Bevacizumab promotes cancer metastasis by activating M2 macrophage[J].Journal Of Pharmaceutical Research,2016,35(12):683-686[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 4190times   Download 3939次 QR Code for this article
Scan with your phone!
贝伐单抗激活M2巨噬细胞促进肿瘤转移
王卓1,刘怀莹2
Font:Larger+|Default|Smaller-
(1.南京中医药大学药学院,江苏 南京 210023;2.江苏太平洋美诺克生物药业有限公司,江苏 常州 213001)
摘要:
目的 研究贝伐单抗与肿瘤微环境中的巨噬细胞间相互关系,初步探讨临床贝伐单抗治疗肝癌无效的机制。方法 采用免疫组化检测肝癌微环境库否细胞表型。巨噬细胞与肿瘤细胞共培养体系中加入贝伐单抗,采用ELISA方法检测培养体系中炎症因子及血管生长因子的分泌。采用划痕实验检测共培养体系上清对肿瘤细胞迁移的影响。结果 临床标本检测肿瘤微环境中的巨噬细胞为M2型,贝伐单抗显著增加M2型巨噬细胞与肿瘤细胞共培养体系中炎症因子TGFβ、IL-12、IL-10及血管生长因子VEGF的水平,肿瘤细胞迁移显著增加。结论 贝伐单抗激活M2型巨噬细胞,促进炎症因子及血管生长因子分泌,促进肿瘤细胞迁移。
关键词:  贝伐单抗  M2型巨噬细胞  炎症因子  肿瘤转移
DOI:10.13506/j.cnki.jpr.2016.12.001
基金项目:南京中医药大学哲学社会科学项目(No.13XZR19);国家自然科学基金重大研究计划集成项目(No.91529304)
Bevacizumab promotes cancer metastasis by activating M2 macrophage
WANG Zhuo1,LIU Huaiying2
(1.School of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,China;2.Jiangsu Pacific Menoctone Biological Pharmaceutical Co.,Ltd.,Changzhou 213001,China)
Abstract:
Objective To study the relationship between bevacizumab,macrophages,and tumor cells in the tumor microenvironment,and find the potential mechanism of invalid treatment of bevacizumab in HCC (hepatic cell carcinoma).Methods The phenotype of macrophages in HCC was determined by immunohistochemistry.M2 macrophages and tumor cells were cocultured and bevacizumab was added.The release of inflammatory cytokines and vascular growth factor were detected by ELISA.The impact of supernant from coculture system on tumor cell migration was detected.Results Most macrophages in HCC microenvironment had M2 characteristics.Bevacizumab increased the level of inflammatory cytokines and vascular endothelial growth factor (VEGF) significantly in the M2 macrophages and tumor cells coculture system.Supernant from M2 macrophages and tumor cells coculture system promoted tumor cell migration.Conclusion Bevacizumab can activate M2 macrophage and promote cancer metastasis.
Key words:  Bevacizumab  M2 macrophage  Inflammatory cytokines  Tumor cell migration
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.